Login
Research AI
Scans
Tools
Login
Home
Charts
Search
Watchlist
Products
All IPOs

Lenskart Solutions Ltd

FMCGIPO
₹402 - 402
₹402 - 402

We are a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products. We primarily sell prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories, under multiple brands and sub-brands. Our focus markets are India, Southeast Asia, Japan and the Middle East. We operate frame and lens design and eyeglass manufacturing facilities at two locations in India, supplemented by regional facilities in Singapore and the United Arab Emirates. We have an established presence across channels, including our websites, mobile applications and retail stores.

Lot37Min Invest₹14,874Face Value₹2Issue Size₹7,278 CrFresh Issue₹2,150 CrOffer for Sale₹5,128 CrListing Price₹390CMP₹626

Timeline

31 Oct
Bidding opens
4 Nov
Bidding closes
6 Nov
Allotment
7 Nov
Refund & demat credit
10 Nov
Listing

Subscription

Subscription opens once dates are announced

Reports

Offer Details

Terms

Issue Size₹7,278 Cr18.11 Cr shares
Fresh Issue₹2,150 Cr
Offer for Sale₹5,128 Cr
Face Value₹2
Lot Size37 shares
ReservationQIB 75% · NII 15% · RETAIL 10%

Application Sizes

Retail₹14,8741-13 lots
sNII₹2,08,236from 14 lots
bNII₹10,11,432from 68 lots

Managers & Registrar

Lead ManagerKotak Mahindra Capital Company Limited
Co-ManagerMorgan Stanley India Company Private Limited, Avendus Capital Private Limited, Citigroup Global Markets India Private Limited, Axis Capital Limited, Intensive Fiscal Services Private Limited
RegistrarMUFG Intime India Pvt Ltd

Ownership & Proceeds

Offer for Sale

Selling ShareholderShares OfferedAmt ₹ CrPeyush BansalPRMTR2,04,88,978823.66Neha BansalPRMTR10,10,54640.62Amit ChaudharyPRMTR28,68,457115.31Sumeet KapahiPRMTR28,68,457115.31Alpha Wave Ventures LPOTH66,64,179267.90Bay Capital Holdings LtdOTH31,78,826127.79Birdseye View Holdings II Pte. LtdOTH37,32,756150.06Chiratae TrustOTH5,34,53221.49ECLK Innovations LLPOTH1,48,4965.97Epiq Capital B, L.P.OTH10,96,22044.07IDG Ventures India Fund III LLCOTH9,50,28238.20Kariba Holdings IV MauritiusOTH19,09,37276.76Kedaara Capital Fund II LLPOTH73,60,340295.89Kedaara Norfolk Holdings LimitedOTH29,44,137118.35MacRitchie Investments Pte. Ltd.OTH78,58,841315.93Madison India Opportunities V VCCOTH8,21,81333.04PI Opportunities Fund - IIOTH87,01,817349.81Schroders Capital Private Equity Asia Mauritius LimitedOTH1,90,64,344766.39SVF II Lightbulb (Cayman) LimitedOTH2,55,18,0981,025.83Technology Venture FundOTH4,74,44619.07TR Capital II L.P.OTH6,85,45527.56TR Capital III MauritiusOTH39,86,272160.25TR Capital III Mauritius IIOTH46,95,909188.78Total12,75,62,5735,128.02

Shareholding

CategoryPre IPOPost IPOPromoter Group19.9%17.69%Public80.1%82.31%

Objects of the Issue

  1. Capital expenditure towards set-up of new CoCo stores in India
  2. Expenditure for lease/rent/license agreements related payments for our CoCo stores operated by our Company, in India
  3. Investing in technology and cloud infrastructure
  4. Brand marketing and business promotion expenses for enhancing brand awareness
  5. Unidentified inorganic acquisitions and general corporate purposes

Financials

Profit & Loss

Financial YearFY23FY24FY25FY26Latest
RevenueCr3,7885,4286,6538,8149,634
Operating ProfitCr2646739761,7532,005
OPM%7.012.414.719.920.8
PBTCr-9759385680880
PATCr-60-10297501668
EPS-80234

Balance Sheet

Financial YearFY23FY24FY25FY26Latest
Equity CapitalCr1515154347-
ReservesCr5,4415,4735,7858,391-
BorrowingsCr9172,1762,5733,097-
Fixed AssetsCr--6,2637,798-
Total AssetsCr9,5289,53110,47114,413-

Cash Flow

Financial YearFY23FY24FY25FY26Latest
Operating Cash FlowCr954871,2311,670-
Investing Cash FlowCr-2,586159-266-2,725-
Financing Cash FlowCr2,777-722-5351,201-
Net Cash FlowCr285-76430145-

Strengths & Risks

Strengths · as stated in the DRHP
  • Centralized Supply Chain and Automated Manufacturing.
  • In-House Frame and Lens Engineering and Manufacturing Capabilities.
  • Customer-Focused Product Design Capabilities.
  • Lenskart Brand and Portfolio of Owned Sub-brands.
  • Technology First Approach to Customer Experience and Operational Efficiency.
  • Omnichannel Retail Platform.
Show all 7 strengths
Strategies · as stated in the DRHP
  • Increase Markets' Penetration and, Expand Customer Access Across Channels.
  • Strengthen Manufacturing and Supply Chain Capabilities.
  • Continue to Innovate and Expand our Product Portfolio.
  • Invest in New Technologies.
  • Continue to Enhance Customer Experience.
  • Continue to strengthen our brand across our markets.
Risks · as stated in the DRHP
  • The company's cost of raw materials consumed constitutes a significant portion of its expenses (amounting to Rs.4,673.39 million, or 25.45% and Rs.16,229.74 million, or 24.52%, of the company's total expenses in the three months ended June 30, 2025 and the Financial Year 2025, respectively) and delays, interruptions or reduction in the supply of raw materials to manufacture the company's prescription eyeglasses or fluctuations in the prices of its raw materials could adversely affect the company's business, results of operations, financial condition and cash flows.
  • The company manufacture some of its frames in, and import some of the company's raw materials from, the People's Republic of China, including through import of frames through Baofeng Framekart Technology Limited, the company's Joint Venture. Any delay, interruption or reduction in the supply of such frames or other raw materials could adversely affect its business, financial condition, results of operations and cash flows.
  • An inability to maintain or improve the company's capacity utilization levels at the company's manufacturing facilities could have an adverse effect on its business, results of operations, financial condition and cash flows.
  • The Directorate of Enforcement, Gurugram under the Foreign Exchange Management Act, 1999, requested the company for certain information and documents. While the company has provided such requested documents, The company cannot assure you that no regulatory or other actions will be initiated against the Company in the future, in relation to such orders, which could adversely affect its business, reputation, results of operations, financial condition and cash flows.
  • The company's manufacturing facilities are subject to environmental, health, and safety laws and regulations that impose significant compliance costs and liabilities on the company's operations, and any non-compliance or violation could expose the company to legal actions, penalties, and reputational harm.
  • Slowdowns, breakdowns or shutdowns at any of the company's manufacturing facilities could have an adverse effect on its business, results of operations, financial condition and cash flows.
Show all 66 risks